ClinicalTrials.Veeva

Menu

Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead

Abbott logo

Abbott

Status

Completed

Conditions

Multi-site Left Ventricular Pacing

Study type

Observational

Funder types

Industry

Identifiers

NCT01044472
CR-09-048-EU-HF

Details and patient eligibility

About

The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.

Full description

To evaluate the hemodynamic impact of different pacing MSLV configurations.

Enrollment

61 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
  • Patients have signed an informed consent form indicating their willingness to participate to this study.

Exclusion criteria

  • Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
  • Patients with second or third degree AV Block
  • Patients with intrinsic atrial rhythm < 40 bpm
  • Patients with a previously implanted left ventricular pacing lead.
  • Patients who are pregnant.
  • Patients currently participating in a clinical investigation that includes an active treatment arm.
  • Patients under 18 years of age.
  • Patients with a life expectancy of less then 6 months.

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems